POS-202 DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE TREATED WITH MINERALOCORTICOID RECEPTOR ANTAGONISTS: PRE-SPECIFIED ANALYSIS OF THE DAPA-CKD TRIAL
Autor: | Provenzano, M., Jongs, N., Stefánsson, B.V., Chertow, G.M., Langkilde, A.M., McMurray, J.J., Correa-Rotter, R., Rossing, P., Sjöström, C.D., Toto, R.D., Wheeler, D.C., Lambers Heerspink, H. |
---|---|
Zdroj: | In Kidney International Reports February 2022 7(2) Supplement:S86-S87 |
Databáze: | ScienceDirect |
Externí odkaz: |